ArticleFrontiers in microbiology2017

Commentary: Type I CRISPR-Cas targets endogenous genes and regulates virulence to evade mammalian host immunity.

Hanna Müller-Esparza et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.